Indivior Pharmaceuticals, Inc. Share Price
NASDAQ: INDV | Mid CapIndivior Pharmaceuticals, Inc. Stock Performance
Open $39.21 | Prev. Close $38.81 | Circuit Range N/A |
Day Range $38.64 - $39.72 | Year Range $21.50 - $42.72 | Volume 2,24,186 |
Average Traded $39.14 |
Indivior Pharmaceuticals, Inc. Share Price Today
As of 9 August 2026, Indivior Pharmaceuticals, Inc.'s share price is $38.66. The stock opened at $39.21, compared to its previous close of $38.81. During today's trading session, Indivior Pharmaceuticals, Inc.'s share price traded between $38.64 and $39.72, with an average price of $39.18. Over the past 52 weeks, the stock has recorded a high of $42.72 and a low of $21.50. In terms of performance, Indivior Pharmaceuticals, Inc.'s share price has risen by 18.15% over the last six months and is up 59.23% on a year-on-year basis.
Indivior Pharmaceuticals, Inc. Share Price Chart
Indivior Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $4.83B | PE Ratio (TTM) 23.01 | Dividend Yield N/A |
EPS (TTM) $1.68 | Revenue (TTM) $1.24B | Return On Equity (TTM) -214.29% |
Profit Margin 16.95% | Debt to Equity -9.33 | Quarterly Earnings Growth YoY N/A |
Indivior Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Indivior Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Indivior Pharmaceuticals, Inc.
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Indivior Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $39.94 | $38.66 | -3.43% |
Jul 2026 | $41.35 | $40.04 | -2.46% |
Jun 2026 | $35.68 | $41.05 | +13.93% |
May 2026 | $39.13 | $36.03 | -2.07% |
Apr 2026 | $30.87 | $36.79 | +20.66% |
Mar 2026 | $32.21 | $30.49 | -6.82% |
Feb 2026 | $35.44 | $32.72 | -7.57% |
Jan 2026 | $36.21 | $35.40 | -1.34% |
Dec 2025 | $33.55 | $35.88 | +6.77% |
Nov 2025 | $29.68 | $33.60 | +14.42% |
Oct 2025 | $23.25 | $29.37 | +21.82% |
Sep 2025 | $24.30 | $24.11 | -0.70% |
INDV Share Price FAQs
What is Indivior Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Indivior Pharmaceuticals, Inc. stock?
What is INDV's market capitalisation today?
What is INDV's net income for the last quarter?
What is the 5 year returns of INDV?
What is the high & low stock price of INDV today?
Can I buy INDV shares in India?